UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstracts for References 32,33

of 'Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer'

32
TI
Ceritinib vs chemotherapy (CT) in patients (pts) with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC) previously treated with CT and crizotinib (CRZ): Results from the confirmatory phase 3 ASCEND-5 study
AU
Scagliotti G, Kim T, Crino L, Liu G, Gridelli C
SO
ESMO. 2016;#LBA42_PR
 
AD
33
TI
First-line Ceritinib Versus Chemotherapy in Patients With ALK-rearranged (ALK+) NSCLC: A Randomized, Phase 3 Study (ASCEND-4)
AU
De Castro Jr G, Tan DS, Crino L, et al
SO
WCLC. 2016;PL03.07
 
AD